US-based MicroAire Surgical Instruments has acquired NEOSYAD, a developer of technology for adipose tissue engineering. France-based NEOSYAD recently gained CE marking under the European Union’s ...

Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC.

Stem cell technology is revolutionizing cosmetic procedures. These facelifts utilize adipose-derived stem cells, extracted ...

liposuction and adipose tissue (aka fatty issue) engineering functions. The product is said to help optimize operating times. "Neosyad’s advanced adipose tissue technology complements MicroAire ...

Thanks to its patented "all-in-one" concept and integrated proprietary software, AdiMate optimizes operating times by combining the infiltration, liposuction, and adipose tissue preparation ...

The stem cells are supposed to assist in repair of damaged tissue and regeneration of cells. Compared to bone marrow stem cells, adipose stem cells are easier ... Cells collected by liposuction are ...

the global leader in power-assisted liposuction, is pleased to announce the acquisition of NEOSYAD, an innovative medical device company that developed a breakthrough technology for adipose tissue ...